The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
The autosomal recessive hypercholesterolemia (ARH) protein interfaces directly with the clathrin-coat machinery
Abstract
The low density lipoprotein (LDL) receptor plays a pivotal role in cholesterol metabolism. Inherited mutations that disturb the activity of the receptor lead to elevations in plasma cholesterol levels and early-onset coronary atherosclerosis. Defects in either the LDL receptor or apolipoprotein B, the proteinaceous component of LDL particles that binds the LDL receptor, elevate circulating LDL-cholesterol levels in an autosomal-dominant fashion, with heterozygotes displaying values between homozygous and normal individuals. Rarely, similar clinical phenotypes occur with a recessive pattern of inheritance, and several genetic lesions in the autosomal recessive hypercholesterolemia ( ARH ) gene on chromosome 1 have been mapped in this class of patients. ARH has an N-terminal phosphotyrosine-binding (PTB) domain evolutionarily related to that found in Disabled-2 and numb, two endocytic proteins. PTB domains bind to the consensus sequence FXNPXY, corresponding to the internalization motif of the LDL receptor. We show here that in addition to the FXNPXY sequence, ARH binds directly to soluble clathrin trimers and to clathrin adaptors by a mode involving the independently folded appendage domain of the β subunit. At steady state, ARH colocalizes with endocytic proteins in HeLa cells, and the LDL receptor fluxes through peripheral ARH-positive sites before delivery to early endosomes. Because ARH also binds directly to phosphoinositides, which regulate clathrin bud assembly at the cell surface, our data suggest that in ARH patients, defective sorting adaptor function in hepatocytes leads to faulty LDL receptor traffic and hypercholesterolemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The PTB domain of ARH binds to the unphosphorylated FDNPVY internalization sequence in LDLR in a sequence-specific manner.
“In vitro studies with purified recombinant proteins indicate that the PTB domain of ARH binds to the unphosphorylated FDNPVY internalization sequence in LDLR in a sequence-specific manner (8,9).”
The clathrin box sequence in ARH can mediate high affinity binding to the heavy chain of clathrin.
“The clathrin box sequence in ARH can mediate high affinity binding to the heavy chain of clathrin (8,9).”
Some PTB domains, including the domain in ARH, bind phosphoinositides.
“some PTB domains, including the domain in ARH, bind phosphoinositides (8,11,12).”
ARH encodes a putative adaptor protein that interacts with the cytoplasmic tail of the LDLR, phospholipids, and clathrin and AP-2 in vitro.
“which encodes a putative adaptor protein that interacts with the cytoplasmic tail of the LDLR, phospholipids, and two components of the clathrin endocytic machinery, clathrin and adaptor protein-2 (AP-2) in vitro.”
From The Modular Adaptor Protein Autosomal Recessive Hypercholesterolemia (ARH) Promotes Low Density Lipoprotein Receptor Clustering into Clathrin-coated Pits (2005) · cites this paper as [11]
In vitro pulldown studies defined sequences within ARH that interact with the LDLR, the terminal domain of the heavy chain of clathrin, and β2-adaptin.
“In vitro pulldown studies defined sequences within ARH that interact with the LDLR, the terminal domain of the heavy chain of clathrin, and 2-adaptin, a component of AP-2 (11, 13).”
From The Modular Adaptor Protein Autosomal Recessive Hypercholesterolemia (ARH) Promotes Low Density Lipoprotein Receptor Clustering into Clathrin-coated Pits (2005) · cites this paper as [11]
Residues 212-216 of ARH comprise a clathrin box sequence (LLDLE) that mediates high affinity binding to the terminal domain of the heavy chain of clathrin.
“Residues 212-216 comprise a canonical clathrin box sequence (LLDLE) that mediates high affinity binding to the terminal domain of the heavy chain of clathrin (11,13,14).”
From The Modular Adaptor Protein Autosomal Recessive Hypercholesterolemia (ARH) Promotes Low Density Lipoprotein Receptor Clustering into Clathrin-coated Pits (2005) · cites this paper as [11]
Data from in vitro pull-down experiments are consistent with ARH functioning as an endocytic adaptor that links the LDLR to structural components of the coated pit.
“Data from in vitro pull-down experiments are consistent with the hypothesis that ARH functions as an endocytic adaptor that links the LDLR to structural components of the coated pit (11,13).”
From The Modular Adaptor Protein Autosomal Recessive Hypercholesterolemia (ARH) Promotes Low Density Lipoprotein Receptor Clustering into Clathrin-coated Pits (2005) · cites this paper as [11]
Amino acids 44-178 of ARH encode a PTB domain that binds the FDNPVY sequence in the LDLR cytoplasmic tail and phosphoinositides.
“Amino acids 44 -178 encode a phosphotyrosine binding (PTB) domain that binds the internalization sequence (FDNPVY) in the LDLR cytoplasmic tail (11,13) and phosphoinositides (11).”
From The Modular Adaptor Protein Autosomal Recessive Hypercholesterolemia (ARH) Promotes Low Density Lipoprotein Receptor Clustering into Clathrin-coated Pits (2005) · cites this paper as [11]
Substitution of the tyrosine in the FDNPVY motif (Tyr807) with alanine resulted in a failure of ARH to promote clustering of LDLRs in WIF-B cells.
“Substitution of the tyrosine in the FDNPVY motif (Tyr 807 ) with alanine, which markedly reduced the interaction between ARH and the LDLR tail in vitro (11,13), also resulted in a failure of ARH to promote clustering of LDLRs in the WIF-B cells.”
From The Modular Adaptor Protein Autosomal Recessive Hypercholesterolemia (ARH) Promotes Low Density Lipoprotein Receptor Clustering into Clathrin-coated Pits (2005) · cites this paper as [11]
The vast majority of LDLRs in lymphocytes are located in intracellular, EEA1-positive vesicles.
“In contrast the vast majority of LDLRs in lymphocytes are located in intracellular, EEA1-positive vesicles (10 -12).”
From The Modular Adaptor Protein Autosomal Recessive Hypercholesterolemia (ARH) Promotes Low Density Lipoprotein Receptor Clustering into Clathrin-coated Pits (2005) · cites this paper as [11]
Following lipoprotein binding, the LDLR adaptor protein ARH binds to the intracellular NPxY motif in the cytoplasmic tail of LDLR.
“Following lipoprotein binding, the LDLR adaptor protein autosomal recessive hypercholesterolemia protein93,94 (ARH) binds to the intracellular NPxY motif in the cytoplasmic tail of LDLR (Fig. 6A).”
From Pathways and Molecular Mechanisms Governing LDL Receptor Regulation (2025) · cites this paper as [94]
The phosphotyrosine-binding sequence also binds inositol phospholipids, which may anchor the protein to the plasma membrane.
“The phosphotyrosine-binding sequence also binds inositol phospholipids, which may anchor the protein to the plasma membrane (11).”
In non-confluent, non-polarized HepG2 cells, the ARH signal appears punctate and homogenously dispersed throughout the cytoplasm.
“As previously described for primary cultured fibroblasts and the HeLa epithelial cell line (11), we found that in non-confluent, non-polarized HepG2 cells the ARH signal appears punctate and homogenously dispersed throughout the cytoplasm (Fig. 1A).”
ARH is associated with β-adaptin and Dab2.
“We found that ARH is associated with -adaptin and Dab2, in agreement with similar findings by Mishra et al. (11).”
Citations
Cites
Disabled‐2 exhibits the properties of a cargo‐selective endocytic clathrin adaptor
Mishra, S. K., Keyel, P. A., Hawryluk, M. J., Agostinelli, N. R., Watkins, S. C., & Traub, L. M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf487 · Cited by 302
Self-citationARH Is a Modular Adaptor Protein That Interacts with the LDL Receptor, Clathrin, and AP-2
He, G., Gupta, S., Yi, M., Michaely, P., Hobbs, H. H., & Cohen, J. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208539200 · Cited by 232
Experiences with the Homozygous Cases of Familial Hypercholesterolemia
Khachadurian, A. K., & Uthman, S. M. (1973) · Annals of Nutrition and Metabolism · doi:10.1159/000175431 · Cited by 185
Flagged first, then by citations
Research works printed but not linked: 47
- 10.1016/S0021-9258(19)39742-X · DOI · Paper page
- 10.1016/0092-8674(86)90533-7 · DOI · Paper page
- 10.1083/jcb.145.5.923 · DOI · Paper page
- 10.1126/science.282.5392.1327 · DOI
- 10.1074/jbc.273.27.17056 · DOI · Paper page
- 10.1002/j.1460-2075.1991.tb04888.x · DOI
- 10.1034/j.1600-0854.2002.30808.x · DOI · Paper page
- 10.1172/JCI6677 · DOI · Paper page
- 10.1126/science.1060458 · DOI · Paper page
- 10.1016/S0140-6736(02)07955-2 · DOI · Paper page
- 10.1161/01.RES.0000018002.43041.08 · DOI
- 10.1161/01.ATV.19.3.802 · DOI · Paper page
- 10.1016/S0014-5793(01)03305-1 · DOI
- 10.1128/MCB.19.7.5179 · DOI · Paper page
- 10.1034/j.1600-0854.2001.020206.x · DOI · Paper page
- 10.1074/jbc.M109336200 · DOI
- 10.1083/jcb.151.6.1345 · DOI · Paper page
- 10.1016/S1534-5807(02)00215-0 · DOI
- 10.1073/pnas.96.16.8907 · DOI
- 10.1016/S0969-2126(02)00784-0 · DOI
- 10.1091/mbc.12.7.1925 · DOI
- 10.1074/jbc.M108177200 · DOI · Paper page
- 10.1021/bi00314a028 · DOI
- 10.1074/jbc.274.46.33097 · DOI
- 10.1074/jbc.M111587200 · DOI
- 10.1074/jbc.272.23.15011 · DOI
- 10.1126/science.280.5362.431 · DOI
- 10.1073/pnas.97.3.1096 · DOI
- 10.1016/S0962-8924(01)02043-8 · DOI · Paper page
- 10.1034/j.1600-0854.2002.30804.x · DOI
- 10.1038/35044540 · DOI
- 10.1523/JNEUROSCI.20-23-08667.2000 · DOI
- 10.1038/29555 · DOI · Paper page
- 10.1111/j.1365-2362.1995.tb01709.x · DOI · Paper page
- 10.1126/science.1061815 · DOI
- 10.1093/emboj/21.7.1555 · DOI · Paper page
- 10.1083/jcb.108.2.389 · DOI
- 10.1007/BF00500626 · DOI
- 10.1177/39.8.1906908 · DOI
- 10.1016/S0092-8674(02)00735-3 · DOI · Paper page
- 10.1016/S0960-9822(01)00240-8 · DOI
- 10.1126/science.1075327 · DOI · Paper page
- 10.1016/S0092-8674(01)00299-9 · DOI
- 10.1083/jcb.149.1.67 · DOI · Paper page
- 10.1016/S0021-9258(19)47222-0 · DOI
- 10.1002/j.1460-2075.1993.tb06219.x · DOI
- 10.1093/emboj/19.16.4216 · DOI
Cited by
Sorted by citations
The adaptor protein Dab2 sorts LDL receptors into coated pits independently of AP-2 and ARH
Maurer, M. E., & Cooper, J. A. (2006) · Journal of Cell Science · doi:10.1242/jcs.03217 · Cited by 195
Cargo- and adaptor-specific mechanisms regulate clathrin-mediated endocytosis
Mettlen, M., Loerke, D., Yarar, D., Danuser, G., & Schmid, S. L. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200908078 · Cited by 177
Focusing on clathrin-mediated endocytosis.
Rappoport, J. Z. (2008) · Biochemical Journal · doi:10.1042/bj20080474 · Cited by 172
Endocytosis in the context-dependent regulation of individual and collective cell properties
Sigismund, S., Lanzetti, L., Scita, G., & Di Fiore, P. P. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00375-5 · Cited by 132
Keyel, P. A., Mishra, S. K., Roth, R., Heuser, J. E., Watkins, S. C., & Traub, L. M. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-05-0421 · Cited by 134
Self-citationGaruti, R., Jones, C., Li, W.-P., Michaely, P., Herz, J., Gerard, R. D., Cohen, J. C., & Hobbs, H. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509394200 · Cited by 91
Michaely, P., Li, W.-P., Anderson, R. G. W., Cohen, J. C., & Hobbs, H. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405242200 · Cited by 66
Sirinian, M. I., Belleudi, F., Campagna, F., Ceridono, M., Garofalo, T., Quagliarini, F., Verna, R., Calandra, S., Bertolini, S., Sorice, M., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504343200 · Cited by 42
Pathways and Molecular Mechanisms Governing LDL Receptor Regulation
Schmidt, H. M., Jarrett, K. E., de Aguiar Vallim, T. Q., & Tarling, E. J. (2025) · Circulation Research · doi:10.1161/circresaha.124.323578 · Cited by 33
Endocytic adaptors Arh and Dab2 control homeostasis of circulatory cholesterol
Tao, W., Moore, R., Meng, Y., Smith, E. R., & Xu, X.-X. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m063065 · Cited by 32
Eden, E. R., Sun, X.-M., Patel, D. D., & Soutar, A. K. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm232 · Cited by 27
Metadata
- Authors
- Mishra, S. K., Watkins, S. C., & Traub, L. M.
- Affiliations
- Department of Cell Biology and Physiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261 USA
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-11-25
- Volume
- 99
- Issue
- 25
- Pages
- 16099-16104
- ISSN
- 0027-8424
- 1091-6490
- Cited by
- 155
- References
- 3
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review